- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Ryan Huey: Expansion of Patient Support, Care Key to Improve Value-Based Oncology
There are various areas across different patient care and support perspectives that offer opportunities to improve value-based care in oncology, said Ryan Huey, MD, gastrointestinal medical oncologist at MD Anderson Cancer Center in Houston, Texas.
Patient services across various perspectives such as direct patient care and patient support are areas that health systems can expand upon to improve value-based oncology care, said Ryan Huey, MD gastrointestinal medical oncologist at MD Anderson Cancer Center in Houston, Texas.
Transcript
What actions can health systems take to improve value-based oncology care within their organizations?
I think from a direct patient care perspective, there's a role to think about the expanded use of telemedicine and also potentially, chemotherapy even at home, or certainly closer to where a patient lives as opposed to in a traditional infusion suite or a hospital. From a support services perspective, there's a role to expand a lot of services. Some of these were described in the Oncology Care Model such as social work or nutritional support or navigation, physical therapy, palliative care; these are things that are not traditionally reimbursed in a fee-for-service environment, however, can lead to improved outcomes for patients or reduced costs throughout the patient journey. So, this is an excellent way to also think about expanding the use of value-based care in the oncology space
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen
Accessing pediatric dermatology care is challenging due to a shortage of specialists and general dermatologists' reluctance to treat children, but increasing their comfort level with seeing children could help bridge the gap, explained Elizabeth Garcia Creighton, of University of Colorado School of Medicine.
Read More
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
